Medical Device Design Team Receives Bronze Award in Inventors Competition
Four UC alumni received the 2011 Collegiate Inventors Competition's
Bronze Award this month for
their invention for pediatric ICU patients.
James Lee, Colin Mitchell, Lauren Riesenberg and Meghan Moore developed their device as part of their senior project in the department of biomedical engineerings Medical Device Innovation and Entrepreneurship Program (MDIEP).
They presented
the BLINX device to science and intellectual property experts, as well as inductees to the National Inventors Hall of Fame, as part of the competition,
which recognizes discoveries and patentable innovations from undergraduates and graduate students across the country. Mitchell, Riesenberg and Moore majored in biomedical engineering at the College of Engineering and Applied Sciences. Lee graduated from the industrial design program at the College of Design, Art, Architecture and Planning.
The device is a fitted mask and bonnet with integrated electronics designed to induce blinking and prevent corneal damage in comatose patients in pediatric intensive care units.
The team worked with William Motley, MD, an ophthalmologist at Cincinnati Childrens Hospital Medical Center and UC assistant professor of clinical ophthalmology, to develop BLINX. Motley often gives consultations on comatose pediatric ICU patients who require neuromuscular blocking drugs to allow for mechanical respiration.
"The blocking drugs also paralyze the muscles around the eyes, says Moore. "For many of those patients, their eyes dont close all the way, leading to corneal dryness, potential corneal abrasion or even vision loss.
The teams device uses topical electrical stimulation to stimulate the muscle around the eyes, inducing a normal blink to hydrate the eye and prevent corneal damage before it starts. BLINX is designed to provide a cycle of blinking for 10 minutes, producing a blink every six seconds, followed by a rest cycle of 30 minutes, for as long as patients need it.
Moore says the team was "excited and honored to participate in the competition.
"We submitted our project for the competition in the spring quarter, but since weve graduated, weve all moved on with our lives, she says. "This competition allows us to come full circle with our project and stay in touch as a team. Theres huge potential for this device.
Introduced by the National Inventors Hall of Fame in 1990, the Collegiate Inventors Competition annually rewards individuals or teams for innovative work and scientific achievement.
The BLINX device is designed as a fitted mask and bonnet with integrated electronics designed to induce blinking.
UC students James Lee, Colin Mitchell, Lauren Riesenberg and Meghan Moore developed their BLINX device as part of their senior project in the department of biomedical engineering s Medical Device Innovation and Entrepreneurship Program.
This future version of BLINX would be made of wireless stimulators attached to the patient's face.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.